To tackle the human health challenges that face the world today, the FNIH develops collaborations with top experts from government, industry, academia and the not-for-profit sector and provides a neutral environment where we can work productively toward a common goal.
The National Institutes of Health Geroscience Interest Group is hosting a two-day Summit to bring together leading researchers, innovators and public advocates from academia, industry, the non-profit sector and the NIH to discuss geroscience concepts and potential opportunities to advance research on chronic diseases that incorporate principles of geroscience.
Project results will help determine the effect of chemotherapy on malignant and non-malignant cells including immune cells. New biomarkers characterizing the TME before and after chemotherapy may be discovered that reflect cell composition, cell states, and cell-cell interaction.